| Market Cap | ₹93,568Cr |
| ROE | 11.45% |
| P/E Ratio(TTM) | 52.74 |
| EPS(TTM) | 42.98 |
| P/B Ratio | 6.12 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.32 |
| Book Value | 370.34 |
| Debt to Equity | 0.55 |
| Face Value | 1 |
| Parent Organisation | Mankind Pharma |
| Managing Director | Mr. Rajeev Juneja |
| NSE Symbol | MANKIND |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 40.19 | ||
| Cipla | NA (0.00%) | 22.77 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.11 | ||
| Zydus Lifesciences | NA (0.00%) | 18.89 |